No Detail Found!

Atropine plus omeprazole for acute gastritis: Efficacy and safety analysis

Author(s)
Huijie Liang Jian'ou Municipal Hospital, Nanping, Fujian, China
Houyu Yan Jian'ou Municipal Hospital, Nanping, Fujian, China
Abstract
This article primarily discusses the efficacy and safety of atropine (ATR) plus omeprazole (OME) for the treatment of acute gastritis (AG). From May 2022 to May 2024, 95 AG patients were selected, including 50 cases treated with ATR+OME (observation group) and 45 cases with anisodamine (ADM) plus OME (control group). Comparative analyses of the following dimensions were then carried out: Clinical efficacy, safety (xerostomia, palpitations, and headaches), symptom remission time (stomach pain, abdominal distension and nausea and vomiting), serum inflammatory factors (tumor necrosis factor [TNF]-a, interleukin [IL]-6 and interferon [IFN]-ß) and plasma gastrointestinal hormones (epidermal growth factor [EGF], gastrin [GAS] and somatostatin [SS]). After analysis, the observation group had a higher total effective rate, a lower overall incidence of adverse reactions and a shorter remission time of symptoms such as stomach pain, abdominal distension, and nausea and vomiting than the control group, all with statistical significance. Moreover, compared with the baseline (before medication) and the control group, TNF-a, IL-6, IFN-ß and GAS were reduced statistically in the observation group after medication, while EGF and SS were markedly increased. Thus, ATR plus OME has significant efficacy in the treatment of AG while ensuring high clinical safety, which deserves clinical promotion.
Publication Details
Page(s) 1207-1212
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
Efficacy, Safety, Omeprazole, atropine, acute gastritis
References
Arciniega-Martínez IM,Pacheco-Yepez J,SantamariaChávez MM,Rebollar-Ruíz XA,Cárdenas-Jaramillo LM,Jarillo-Luna RA,Campos-Rodríguez R,DragoSerrano ME,Reséndiz-Albor AA .2022 .Muscarinic receptors control markers of inflammation in the small intestine of BALB/c mice. J Neuroimmunol, 362 : 577764.
Bauditz J,Ortner M,Bierbaum M,Niedobitek G,Lochs H,Schreiber S H .1999 .Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol, 117(2) : 316-323.
Bender BJ,Ozuah PO,Crain EF .2007 .Oral rehydration therapy: Is anyone drinking?. Pediatr Emerg Care, 23(9) : 624-626.
Chamniansawat S,Kampuang N,Suksridechacin N,Thongon N N .2021 .Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats. Anat Sci Int., 96(1) : 142-156.
Chen P,Li L,Wang H,Zhao J,Cheng Y,Xie J,Cao M,Huang L,Yang F,Chen H,Chen J,Su M,Xu Y,Zheng F,Geng L,Xu W,Gong S W .2020 .Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells. Biomed Pharmacother, 130 : 110472.
Chow CM,Leung AK,Hon KL .2010 .Acute gastroenteritis: From guidelines to real life. Clin Exp Gastroenterol, 3 : 97-112.
Danaie E,Masoudi S,Masnabadi N S .2023 .Chemical composition analysis of Atropa belladonna grown in Iran and evaluation of antibacterial properties of extract-loaded nanofibers. Iran J. Pharm. Res., 22(1) : e137839.
Duque-Buitrago LF,Tornero-Martínez A,LoeraCastañeda V,Mora-Escobedo R .2023 .Use of food and food-derived products in the treatment of gastritis: A systematic review. Crit. Rev. Food Sci. Nutr, 63(22) : 5771-5782.
El-Zaatari M,Bishu S,Zhang M,Grasberger H,Hou G,Haley H,Humphries B,Syu LJ,Dlugosz AA,Luker K,Luker GD,Eaton K,Kamada N,Cascalho M,Kao JY M .2020 .Aim2-mediated/IFN-β-independent regulation of gastric metaplastic lesions via CD8+ T cells. JCI Insight, 5(5) : 1-15.
Feyisa ZT,Woldeamanuel BT .2021 .Prevalence and associated risk factors of gastritis among patients visiting Saint Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia. PLoS One, 16(2) : e0246619.
Fuentes JM,Fulton WB,Nino D,Talamini MA,Maio AD .2008 .Atropine treatment modifies LPS-induced inflammatory response and increases survival. Inflamm Res., 57(3) : 111-117.
Granado-Villar D,Cunill-De Sautu B and Granados A .2012 .Acute gastroenteritis. Pediatr Rev., 33(11) : 487-494.
Graves NS .2013 .Acute gastroenteritis. Prim Care, 40(3) : 727-741.
Kang SJ,Kim JG,Moon HS,Kook MC,Lee JY,Bang CS,Tae CH,Gong EJ,Nam SY,Kim HJ .2023 .Clinical practice guideline for gastritis in Korea. J. Korean Med, 38(13) : e115.
Kayaçetin S Guresci S ,Gastroenterol J. .2014 .What is gastritis? What is gastropathy? How is it classified? Turk. , 25(3) : 233-247.
Krueger D,Michel K,Allam S,Weiser T,Demir IE,Ceyhan GO,Zeller F,Schemann M .2013 .Effect of hyoscine butylbromide (Buscopan®) on cholinergic pathways in the human intestine. Neurogastroenterol, 25(8) : e530-539.
Le Merdy M,Tan ML,Sun D,Ni Z,Lee SC,Babiskin A,Zhao L .2021 .Physiologically based pharmacokinetic modeling approach to identify the drug-drug interaction mechanism of nifedipine and a proton pump inhibitor, omeprazole. Eur. J. Drug Metab, 46(1) : 41-51.
Leja M,Wex T,Malfertheiner P .2012 .Markers for gastric cancer premalignant lesions: Where do we go? Dig Dis. , 30(3) : 268-276.
Lin X,Chen H,Lin YN .2021 .The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: A systematic review and meta-analysis. Ann. Palliat. Med, 10(9) : 9535-9543.
Müller-Krampe B,Oberbaum M,Klein P. Weiser M .2007 .Effects of Spascupreel versus hyoscine butylbromide for gastrointestinal cramps in children. Pediatr. Int., 49(3) : 328-334.
Marques MB,Lima TF,Guaratti M,Costa MC,Saheb JL,Brunetti IL,Assis RP,Baviera AM .2024 .Assessment of the antioxidant status and markers of oxidative stress in patients with kidney failure: Effects of a hemodialysis session. An. Acad. Bras, 96(suppl 1) : e20240297.
Ozuah PO,Avner JR,Stein RE .2002 .Oral rehydration, emergency physicians and practice parameters: A national survey. Pediatrics, 109(2) : 259-261.
Ryoo E .2021 .Causes of acute gastroenteritis in Korean children between 2004 and 2019. , 64(6) : 260-268.
Sánchez-Trigueros MI,Méndez-Cruz F,Pineda-Peña EA,Rivera-Espinoza Y,Castañeda-Hernández G,Chávez-Piña AE .2021 .Synergistic protective effects between docosahexaenoic acid and omeprazole on the gastrointestinal tract in the indomethacin-induced injury model. Drug Dev. Res., 82(4) : 543-552.
Schmidt MA,Groom HC,Rawlings AM,Mattison CP,Salas SB,Burke RM,Hallowell BD,Calderwood LE,Donald J,Balachandran N,Hall AJ .2022 .Incidence, etiology, and healthcare utilization for acute gastroenteritis in the community. United States. Emerg. Infect. Dis., 28(11) : 2234-2242.
Sri Rethinavel H,Selvaraj DB,Balakrishnan SJ,Vergil Andrews JF,Joseph JHM,Kandasamy M .2022 .Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder. Heliyon, 8(6) : e09787.
Tan VP,Wong BC .2011 .Helicobacter pylori and gastritis: Untangling a complex relationship 27 years on. J. Gastroenterol. Hepatol., 26(Suppl 1) : 42-45.
Tian F,Li C,Wang X,Ren S,Li N,Liu Q,Zhou S,Lu Y,Zhao D,Chen X .2015 .Comparative study on pharmacokinetics of a series of anticholinergics, atropine, anisodamine, anisodine, scopolamine and tiotropium in rats. Eur. J. Drug Metab, 40(3) : 245-253.
Topaloglu U,Muftuoglu T,Akturk Z,Ekinci H,Peker O,Unalmiser S O .2004 .Omeprazole is more effective than famotidine for preventing acute gastritis in rats. Surg. Today, 34(8) : 690-694.
Xie CJ,Chen L,Tong FL,Xiao LM,Zhang JC .2012 .Meta analysis of association between TNF-α-308 polymorphism and periodontitis in Chinese Han population. , 21(4) : 447-450.
0

Citations

0

Downloads

90

Views